|Bid||0.000 x 0|
|Ask||0.000 x 0|
|Day's Range||13.550 - 15.410|
|52 Week Range||5.150 - 19.869|
|Beta (3Y Monthly)||4.05|
|PE Ratio (TTM)||103.25|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Don’t get swept up in all the hoopla over Canadian legalization, where a limited market and falling prices may produce big losses.
HENDERSON, NV / ACCESSWIRE / October 18, 2018 / There has been some bad news in the market recently causing some securities to sell off. This has made for some desirable buying opportunities for savvy ...
CORAL GABLES, FL / ACCESSWIRE / October 18, 2018 / Wednesday marked the "big day" that every cannabisand marijuana stocks enthusiast has been waiting for. The country firmly moved ahead with its program that legalizes the sale of recreationalmarijuana across Canada. With an end to prohibitionin Canada, this marks a point in time that now two countries in the world have legalized cannabis for recreational use.
On October 17, Aurora Cannabis (ACB) (ACBFF) announced that it received sales licenses from Health Canada. Aurora Cannabis stated that with the receipt of this sales license, the company’s dried cannabis and derivative product availability will increase. The company also received a sales license for cannabis soft gel products for its facility located in Quebec.
Recreational cannabis sales began in Canada on October 17, 2018. Canada is only the second country after Uruguay to legalize cannabis. As a powerful, developed nation, Canada may serve as a blueprint for other developed nations around the world.
Cannabis will be legal in Canada starting this Wednesday, generating strong interest from investors eager to get in on a market that analysts and experts expect to be worth billions of dollars.
Following years of debate, adults can begin buying marijuana for recreational use today. Here's what you need to know.
HENDERSON, NV / ACCESSWIRE / October 17, 2018 / Below are a few opportunities to help with one of America's largest problems: opioid addiction.While cannabis stocks have been receiving a lot of the attention ...
The launch of the recreational cannabis industry in Canada will be a volatile ride, but the companies forming the industry seem prepared.
According to Arcview Market Research and its research partner BDS Analytics, over the next 10 years, thelegal cannabis industry will see much progress around the globe. Spending on legal cannabis worldwide is expected to hit $57 billion by 2027. Right now, investors are looking at a number of cannabis companies working to take full advantage of this market boom including Next Green Wave (NGW), Aphria Inc. (APHQF)(APH), and Canopy Growth (CGC)(WEED).
HEXO (HEXO), which has a partnership with Molson Coors, rose almost 5.4% on October 15 to 8.95 Canadian dollars. In the current month, the overall consensus recommendation on HEXO is a “buy,” which remained unchanged from September. The current consensus price target on HEXO in October stood at 8.7 Canadian dollars, which increased slightly from 8.6 Canadian dollars in September.
After historic legislation that moved Canada as the first G7 member state to legalize recreational marijuana, it became official. This has significant implications, especially for marijuana stocks. As such, investors should strongly consider marijuana stocks to buy, irrespective of their personal reservations.
Vic Neufeld , CEO of Aphria, said "Today we celebrate the end of nearly a century of prohibition and the beginning of an exciting new chapter for the cannabis industry. The Cannabis Act, which comes into effect today, cements Canada's global leadership in this rapidly expanding industry. "This is also an exciting day for Aphria as we look back on our journey.
Wednesday will be a big day north of the border, as that's when Canada will become the first major economy to legalize recreational cannabis. Ahead of this landmark event, stocks billed as cannabis-related have been quite volatile.
With the previous presidential administration’s frankness on the matter, marijuana has become more blasé. Naturally, marijuana stocks have also increased in popularity, where we have more choices today than was previously thought possible. For instance, some of the top marijuana stocks are levered toward medical cannabis.
With marijuana headed for legalization in Canada, these penny stocks offer direct exposure and could help you get a piece of the pot.
Emerging businesses often serve as excellent chances to earn outsized profits. One rising out of the shadows recently is the marijuana industry. Bans instituted in the early 20th century drove its cultivation and use of cannabis underground. However, with various trends toward legalization, marijuana stocks have gained interest from investors.
Without a doubt, Canopy Growth (CGC)(WEED) has been one of the hottest cannabis stocks on the market (MJ). The company is one of the most valuable companies, ahead of Aurora Cannabis (ACB) (ACBFF) and Aphria (APHQF). The overall consensus recommendation for Canopy Growth in October is a “buy.” As the above chart shows, two analysts maintained a “strong buy” on the stock, while five analysts maintained a “buy” recommendation on the stock in the current month.
Tomorrow is the big day north of the border. October 17th, 2018, Canada becomes the first major economy to legalize the recreational use of cannabis. Ahead of this landmark event, stocks labeled as Cannabis stocks have been quite volatile.
Traditional players have shown a great deal of interest in forming partnerships with cannabis companies, and Aphria (APHQF) was recently reported to be in talks with tobacco giant Altria. The overall consensus analyst recommendation for Aphria in October was a “buy,” which was unchanged from the previous month. Overall, analysts remained bullish on Aphria in October for the next-12-month period.
NEW YORK, NY / ACCESSWIRE / October 16, 2018 / U.S. markets failed to remain in the green on Monday as a technology sector selloff erased earlier gains. Tech giants Netflix and Apple both dropped more ...
LEAMINGTON, ON , Oct. 16, 2018 /CNW/ - Aphria Inc. ("Aphria" or the "Company") (TSX: APH and US OTC: APHQF) commends the Government of the United Kingdom for its decision last week to legalize medical cannabis.
Prospective investors in cannabis companies like Aphria Inc (OTC: APHQF), Aurora Cannabis Inc (OTC: ACBFF) and Cronos Group Inc (NASDAQ: CRON) should take another metric into account: the companies' Latin American presence. A new report from Prohibition Partners shows that the Latin American cannabis market could reach a value of $12 billion within the next decade. Latin America has a population of over 650 million, but the continent's total health care costs are around $354 billion — significantly smaller than Europe, which has a population of 740 million and health care spending of more than $2.6 trillion.
HENDERSON, NV / ACCESSWIRE / October 15, 2018 / A fascinating biotechnology firm PPCB (Propanc Biopharma, Inc.) erupted for over 7000% in the between late August and early September going from a low of $0.0039 to a high of over $0.28, the stock is still holding a substantial gain of 1795% as of the close on Friday. PPCB may start receiving increased attention from the street at any moment. PPCB has a 52 week high of $0.77.